-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M+hPfqcR0/5Tqxhuhcj/6ZHVDB/Fee6KZvrcFwaa5YWcVyrk6dc1bqEnd6olG6YZ NnN+tOvyFyxFc6mTpEGbyg== 0001104659-04-036224.txt : 20041115 0001104659-04-036224.hdr.sgml : 20041115 20041115200517 ACCESSION NUMBER: 0001104659-04-036224 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041111 FILED AS OF DATE: 20041115 DATE AS OF CHANGE: 20041115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSKARYOTIC THERAPIES INC CENTRAL INDEX KEY: 0000885259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043027191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 ALBANY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6173490200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirby Neil CENTRAL INDEX KEY: 0001308655 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21481 FILM NUMBER: 041147691 BUSINESS ADDRESS: BUSINESS PHONE: 617-349-0200 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 a3.xml 3 X0202 3 2004-11-11 0 0000885259 TRANSKARYOTIC THERAPIES INC TKTX 0001308655 Kirby Neil 700 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 Sr VP, Strategic Prod Devlpmt. Stock Option (right to buy) 42.64 2012-01-02 Common Stock 14070 D Stock Option (right to buy) 42.64 2012-01-02 Common Stock 45930 D Stock Option (right to buy) 5.84 2013-03-28 Common Stock 18000 D Stock Option (right to buy) 9.76 2013-06-11 Common Stock 4500 D Stock Option (right to buy) 10.62 2014-03-24 Common Stock 15000 D The option becomes exercisable in six approximately equal annual installments beginning on January 2, 2003. The option becomes exercisable in four approximately equal semi-annual installments beginning on September 28, 2003. The option becomes exercisable in four approximately equal semi-annual installments beginning on December 11, 2003. The option becomes exercisable in three approximately equal annual installments beginning on March 24, 2005. /s/ Neil Kirby 2004-11-15 -----END PRIVACY-ENHANCED MESSAGE-----